Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19
CONCLUSIONS: Full COVID-19 vaccination conferred protection against school absenteeism in hospitalized school-aged children with COVID-19.PMID:38556391 | DOI:10.1016/j.vaccine.2024.03.075 (Source: Vaccine)
Source: Vaccine - March 31, 2024 Category: Allergy & Immunology Authors: Helena C Maltezou Stavroula Kontogianni Elisavet Michailidou Eleni Vergadi Theodoros V Giannouchos Evangelia Steletou Nikolaos V Sipsas Emmanouil Galanakis George A Syrogiannopoulos Emmanuel Roilides Source Type: research
Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease
CONCLUSION: The number of benefits of vaccination identified strongly related to vaccination likelihood. Affirmative provider recommendations correlated with increased vaccination likelihood in AD patients. Clinical conversations centered on the benefits of COVID-19 vaccination may help increase vaccine acceptance.PMID:38556392 | DOI:10.1016/j.vaccine.2024.03.067 (Source: Vaccine)
Source: Vaccine - March 31, 2024 Category: Allergy & Immunology Authors: Jenny D Gong Emma Barnboym Megan O'Mara Natalie Gurevich Maya Mattar Donald D Anthony Adam T Perzynski Nora G Singer Source Type: research
Review of mathematical models of Neisseria gonorrhoeae vaccine impact: Implications for vaccine development
Vaccine. 2024 Mar 30:S0264-410X(24)00380-3. doi: 10.1016/j.vaccine.2024.03.068. Online ahead of print.ABSTRACTAn effective prophylactic vaccine for prevention of Neisseria gonorrhoeae infection would have a major impact on sexual and reproductive health worldwide. Interest in developing gonorrhoea vaccines is growing due to the reported high rates of N. gonorrhoeae infections globally, and the threat of antimicrobial resistance. Several gonorrhoea vaccine candidates are currently under evaluation and various mathematical models have been used to assess the potential population-level impact a gonorrhoea vaccine may have onc...
Source: Vaccine - March 31, 2024 Category: Allergy & Immunology Authors: Thilini N Padeniya Ben B Hui James G Wood David G Regan Kate L Seib Source Type: research
Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19
CONCLUSIONS: Full COVID-19 vaccination conferred protection against school absenteeism in hospitalized school-aged children with COVID-19.PMID:38556391 | DOI:10.1016/j.vaccine.2024.03.075 (Source: Vaccine)
Source: Vaccine - March 31, 2024 Category: Allergy & Immunology Authors: Helena C Maltezou Stavroula Kontogianni Elisavet Michailidou Eleni Vergadi Theodoros V Giannouchos Evangelia Steletou Nikolaos V Sipsas Emmanouil Galanakis George A Syrogiannopoulos Emmanuel Roilides Source Type: research
Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease
CONCLUSION: The number of benefits of vaccination identified strongly related to vaccination likelihood. Affirmative provider recommendations correlated with increased vaccination likelihood in AD patients. Clinical conversations centered on the benefits of COVID-19 vaccination may help increase vaccine acceptance.PMID:38556392 | DOI:10.1016/j.vaccine.2024.03.067 (Source: Vaccine)
Source: Vaccine - March 31, 2024 Category: Allergy & Immunology Authors: Jenny D Gong Emma Barnboym Megan O'Mara Natalie Gurevich Maya Mattar Donald D Anthony Adam T Perzynski Nora G Singer Source Type: research
Review of mathematical models of Neisseria gonorrhoeae vaccine impact: Implications for vaccine development
Vaccine. 2024 Mar 30:S0264-410X(24)00380-3. doi: 10.1016/j.vaccine.2024.03.068. Online ahead of print.ABSTRACTAn effective prophylactic vaccine for prevention of Neisseria gonorrhoeae infection would have a major impact on sexual and reproductive health worldwide. Interest in developing gonorrhoea vaccines is growing due to the reported high rates of N. gonorrhoeae infections globally, and the threat of antimicrobial resistance. Several gonorrhoea vaccine candidates are currently under evaluation and various mathematical models have been used to assess the potential population-level impact a gonorrhoea vaccine may have onc...
Source: Vaccine - March 31, 2024 Category: Allergy & Immunology Authors: Thilini N Padeniya Ben B Hui James G Wood David G Regan Kate L Seib Source Type: research
Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19
CONCLUSIONS: Full COVID-19 vaccination conferred protection against school absenteeism in hospitalized school-aged children with COVID-19.PMID:38556391 | DOI:10.1016/j.vaccine.2024.03.075 (Source: Vaccine)
Source: Vaccine - March 31, 2024 Category: Allergy & Immunology Authors: Helena C Maltezou Stavroula Kontogianni Elisavet Michailidou Eleni Vergadi Theodoros V Giannouchos Evangelia Steletou Nikolaos V Sipsas Emmanouil Galanakis George A Syrogiannopoulos Emmanuel Roilides Source Type: research
Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease
CONCLUSION: The number of benefits of vaccination identified strongly related to vaccination likelihood. Affirmative provider recommendations correlated with increased vaccination likelihood in AD patients. Clinical conversations centered on the benefits of COVID-19 vaccination may help increase vaccine acceptance.PMID:38556392 | DOI:10.1016/j.vaccine.2024.03.067 (Source: Vaccine)
Source: Vaccine - March 31, 2024 Category: Allergy & Immunology Authors: Jenny D Gong Emma Barnboym Megan O'Mara Natalie Gurevich Maya Mattar Donald D Anthony Adam T Perzynski Nora G Singer Source Type: research
Testing the impact of differing behavioural science informed text message content in COVID-19 vaccination invitations on vaccine uptake: A randomised clinical trial
This study investigated the impact of behavioural science-informed text message strategies on COVID-19 vaccination rates in 18-39-year-olds in an area of low uptake in London during the first vaccination offer round in the United Kingdom. This three-armed randomised trial recruited unvaccinated residents of an urban Central London suburb being offered their first vaccination between May and June 2021. Participants were randomised to receive the control (current practice) text message or one of two different behavioural science-informed COVID-19 vaccine invitation strategies. Both intervention strategies contained the phras...
Source: Vaccine - March 29, 2024 Category: Allergy & Immunology Authors: Sarah W Huf Kate Grailey Roberto Fernandez Crespo Lena Woldmann Matthew Chisambi Helen Skirrow Kirstie Black Bahram Hassanpourfard Joe Nguyen Bob Klaber Ara Darzi Source Type: research
Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance
CONCLUSIONS: In contrast to PCV10, PCV13 vaccination consistently protected against 6C IPD and NPC in children, and provided some level of indirect protection to adults, supporting that serotype 6A but not 6B provides cross-protection to 6C. Vaccine policy makers and regulators should consider the effects of serotype 6A-containing PCVs against serotype 6C disease in their decisions.PMID:38553292 | DOI:10.1016/j.vaccine.2024.03.065 (Source: Vaccine)
Source: Vaccine - March 29, 2024 Category: Allergy & Immunology Authors: Lindsay R Grant Germaine Hanquet Ingrid T Sep úlveda-Pachón Christian Theilacker Marc Baay Mary P E Slack Luis Jodar Bradford D Gessner Source Type: research
Testing the impact of differing behavioural science informed text message content in COVID-19 vaccination invitations on vaccine uptake: A randomised clinical trial
This study investigated the impact of behavioural science-informed text message strategies on COVID-19 vaccination rates in 18-39-year-olds in an area of low uptake in London during the first vaccination offer round in the United Kingdom. This three-armed randomised trial recruited unvaccinated residents of an urban Central London suburb being offered their first vaccination between May and June 2021. Participants were randomised to receive the control (current practice) text message or one of two different behavioural science-informed COVID-19 vaccine invitation strategies. Both intervention strategies contained the phras...
Source: Vaccine - March 29, 2024 Category: Allergy & Immunology Authors: Sarah W Huf Kate Grailey Roberto Fernandez Crespo Lena Woldmann Matthew Chisambi Helen Skirrow Kirstie Black Bahram Hassanpourfard Joe Nguyen Bob Klaber Ara Darzi Source Type: research
Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance
CONCLUSIONS: In contrast to PCV10, PCV13 vaccination consistently protected against 6C IPD and NPC in children, and provided some level of indirect protection to adults, supporting that serotype 6A but not 6B provides cross-protection to 6C. Vaccine policy makers and regulators should consider the effects of serotype 6A-containing PCVs against serotype 6C disease in their decisions.PMID:38553292 | DOI:10.1016/j.vaccine.2024.03.065 (Source: Vaccine)
Source: Vaccine - March 29, 2024 Category: Allergy & Immunology Authors: Lindsay R Grant Germaine Hanquet Ingrid T Sep úlveda-Pachón Christian Theilacker Marc Baay Mary P E Slack Luis Jodar Bradford D Gessner Source Type: research
Nanopore sequencing in distinguishing between wild-type and vaccine strains of Varicella-Zoster virus
CONCLUSION: This study validates that nanopore sequencing is a reliable method for differentiating between the wild-type and vaccine strains of VZV. Its ability to produce long-read sequences is remarkable, allowing simultaneous confirmation of known SNPs and the detection of new mutations. Nanopore sequencing can serve as a valuable tool for the swift and precise identification of wild-type and vaccine strains and has potential applications in future VZV surveillance.PMID:38548526 | DOI:10.1016/j.vaccine.2024.03.046 (Source: Vaccine)
Source: Vaccine - March 28, 2024 Category: Allergy & Immunology Authors: Yuto Fukuda Takako Suzuki Ken-Ichi Iwata Kazunori Haruta Makoto Yamaguchi Yuka Torii Atsushi Narita Hideki Muramatsu Yoshiyuki Takahashi Jun-Ichi Kawada Source Type: research
Nanopore sequencing in distinguishing between wild-type and vaccine strains of Varicella-Zoster virus
CONCLUSION: This study validates that nanopore sequencing is a reliable method for differentiating between the wild-type and vaccine strains of VZV. Its ability to produce long-read sequences is remarkable, allowing simultaneous confirmation of known SNPs and the detection of new mutations. Nanopore sequencing can serve as a valuable tool for the swift and precise identification of wild-type and vaccine strains and has potential applications in future VZV surveillance.PMID:38548526 | DOI:10.1016/j.vaccine.2024.03.046 (Source: Vaccine)
Source: Vaccine - March 28, 2024 Category: Allergy & Immunology Authors: Yuto Fukuda Takako Suzuki Ken-Ichi Iwata Kazunori Haruta Makoto Yamaguchi Yuka Torii Atsushi Narita Hideki Muramatsu Yoshiyuki Takahashi Jun-Ichi Kawada Source Type: research
Novel nucleotide-packaging vaccine delivers antigen and poly(I:C) to dendritic cells and generate a potent antibody response in vivo
Vaccine. 2024 Mar 26:S0264-410X(24)00364-5. doi: 10.1016/j.vaccine.2024.03.058. Online ahead of print.ABSTRACTAn issue with many current vaccines is the dependency on broadly inflammatory adjuvants, such as aluminum hydroxide or aluminum salts that affect many immune- and non-immune cells. These adjuvants are not necessarily activating all antigen-presenting cells (APCs) that take up the antigen and most likely they also activate APCs with no antigen uptake, as well as many non-immune cells. Conjugation of antigen and adjuvant would enable the use of smaller amounts of adjuvant and avoid unnecessary tissue damage and activ...
Source: Vaccine - March 27, 2024 Category: Allergy & Immunology Authors: Natasja Bruun Marlene F Laursen Rita Carmelo Esben Christensen Trine S Jensen Gunna Christiansen Svend Birkelund Ralf Agger Emil Kofod-Olsen Source Type: research
